2026 December - 11 articles
Background/Objectives: Glucose-lowering treatment can change insulin resistance indices without demonstrating improved insulin sensitivity. We described these changes during sodium–glucose cotransporter-2 (SGLT2) inhibitor therapy in routine ca...
Late distant recurrence in estrogen receptor-positive (ER+) breast cancer raises the question of how disseminated tumor cells resume proliferation years after primary tumor resection. We propose two coupled processes: endocrine–immune condition...
In the original publication [...]
In the original publication [...]
Background/Objectives: Polycystic ovary syndrome (PCOS), renamed polyendocrine metabolic ovarian syndrome (PMOS) in 2026, is a heterogeneous endocrine–metabolic disorder. Asparagus racemosus (Shatavari) is widely used for women’s reproduc...
Background: Large language models (LLMs) can generate clinically relevant information, but safety-related performance in systemic lupus erythematosus (SLE) remains insufficiently characterised. We compared GPT-5.5 Instant (ChatGPT), Claude Sonnet 4.6...
Background: Acute myeloid leukemia (AML) is an aggressive hematologic malignancy in which relapse and treatment resistance remain major clinical challenges. Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, has...
Healthspan, the period of life free from major chronic disease and disability, is a central geroscience outcome, yet its prediction remains difficult due to its multidimensional and heterogeneous nature. In this review, we synthesize advances in arti...
Background: Melatonin concentrations in follicular fluid exceed serum levels, suggesting local ovarian accumulation and a potential role in the follicular microenvironment. Previous studies reporting associations between intrafollicular melatonin and...
The International Journal of Translational Medicine (IJTM) [...]
Background/Objectives: Low-dose phthalate exposure acts as an adjuvant for immunoglobulin production and exacerbates atopic dermatitis (AD)-like lesions; however, research on orally administered di-(2-ethylhexyl) phthalate (DEHP)-mediated AD aggravat...
